vTv Therapeutics (VTVT) Receivables - Net (2017 - 2024)
vTv Therapeutics (VTVT) has disclosed Receivables - Net for 10 consecutive years, with $62000.0 as the latest value for Q4 2024.
- Quarterly Receivables - Net fell 39.22% to $62000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $62000.0 through Dec 2024, down 39.22% year-over-year, with the annual reading at $62000.0 for FY2024, 39.22% down from the prior year.
- Receivables - Net hit $62000.0 in Q4 2024 for vTv Therapeutics, down from $242000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $12.5 million in Q2 2022 to a low of $2000.0 in Q1 2021.
- Historically, Receivables - Net has averaged $1.0 million across 5 years, with a median of $102000.0 in 2023.
- Biggest five-year swings in Receivables - Net: skyrocketed 6528.57% in 2021 and later crashed 93.86% in 2022.
- Year by year, Receivables - Net stood at $158000.0 in 2020, then plummeted by 63.92% to $57000.0 in 2021, then skyrocketed by 203.51% to $173000.0 in 2022, then tumbled by 41.04% to $102000.0 in 2023, then plummeted by 39.22% to $62000.0 in 2024.
- Business Quant data shows Receivables - Net for VTVT at $62000.0 in Q4 2024, $242000.0 in Q3 2024, and $306000.0 in Q2 2024.